Invest in

Biotech Breakthroughs

3.9%
1.9%
0.7%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
3.9%
1.9%
0.7%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
51.2% Research & Diagnostics 29.2%
14.2% Abbott Laboratories ABT 38.9%
9.1% 8xxxxx 8xxxxx 8xxxxxxxxx 8xxx 8xx 88.8%
9.0% 8xxxxxx 8xxxxxxxxxx 8xx 88.8%
4.4% 8xxxxxxxxx 8xxxxxxxxxx 8x 8xxxxxx 8xxxxx 8x 88.8%
4.2% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
3.1% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
2.9% 8xxxx 8xxxxxxxxxx 8xxxxxxxxxxx 8xx 88.8%
2.2% 8xxxxxxxxxx 8xxx 8xx 88.8%
1.2% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
1.1% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
36.5% Mature Biotechnology 2.5%
14.0% Amgen Inc. AMGN 9.8%
10.5% Gilead Sciences Inc. GILD 14.0%
6.6% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
5.4% 8xxxxx 8xxx 8xxx 88.8%
6.1% Other Biotech 40.6%
4.1% 8xxxx 8xx 8xxx 88.8%
1.1% 8xxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
0.9% 8xxxxxxx 8xx 8xxx 88.8%
3.7% Commercial Growth Biotech 16.5%
3.7% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.5% Early Commercial Biotech 8.8%
1.5% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.0% Development Stage Biotech 44.5%
1.0% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%

Quotes delayed 15 mins. Currently Apr 22, 2018 6:14:41 PM. Fields are marked with -- when data is unavailable.